Drug intelligence / Profile preview

FeraMAX Pd

Development stage
Unknown
Lead developer
BioSyent
Modality
Small Molecules
Administration
Oral
01

Overview

FeraMAX Pd is an oral iron supplement developed and marketed by BioSyent, utilizing a patented Polydextrose-Iron Complex (PIC) delivery system. Launched in Canada in 2020 as an evolution of the original FeraMAX 150, it is indicated for the prevention and treatment of iron deficiency and iron deficiency anemia. The PIC technology employs a non-ionic formulation where elemental iron is stable and sequestered within a polydextrose shell. This structure prevents the release of free ionic iron in the stomach, which significantly improves gastrointestinal tolerability and reduces common side effects such as nausea, constipation, and epigastric pain compared to traditional ferrous salts. FeraMAX Pd is available in multiple formats, including Therapeutic 150 capsules and pediatric drops.

Brand names
FeraMAX PdFeraMAX Pd Therapeutic 150
Other names
polydextrose-iron complexPIC

Beyond the preview

Go deeper on FeraMAX Pd.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FeraMAX Pd.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call